1. Catalog
  2. The Lead Episode 112: A Discussion of Brugada Synd ...
Image For Activity Cover
The Lead Episode 112: A Discussion of Brugada Syndrome Ablation for the Prevention of VS Episodes (BRAVE) LIVE from Heart Rhythm 2025 in San Diego
Description
The Lead Episode 112: A Discussion of Brugada Syndrome Ablation for the Prevention of VS Episodes (BRAVE) LIVE from Heart Rhythm 2025 in San Diego.
Learning Objectives
  • Evaluate epicardial catheter ablation targeting the arrhythmogenic substrate in Brugada syndrome patients with implantable cardioverter-defibrillators (ICDs) to prevent ventricular fibrillation (VF).
Article Authors and Podcast Contributors
Article Authors

Frederic Sacher, Tobias Reichlin, Mathieu Le Bloa, Gregoire Massoulie, Xavier Waintraub, Philippe Maury, Daniel Scherr, Romain Tixier, Benoit Guy-Moyat, Josselin Duchateau, Christian Meyer, Melanie Gunawardene, Noemie Bronnec, Estelle Gandjbakhch, Nicolas Derval, Roland Tilz, Mélèze Hocini, Thomas Deneke, Thomas Pambrun, Helmut Pürerfellner, Florian Englert, Elena Sauer, Pierre Jais, Antoine Benard and Hubert Cochet 

Podcast Contributors


Jason T. Jacobson, MD, FHRS, Westchester Medical Center - New York Medical College
Marmar Vaseghi, MD, MS, PhD, FHRS, University of California, Los Angeles
Maynak Sardana, MBBS, MS, Mayo Clinic Arizona

Faculty and Disclosures
All relevant financial relationships have been mitigated.

Host Disclosure(s):

J. Jacobson:

Honoraria/Speaking/Consulting: Zoll Medical, Abbott Medical, Vektor Medical
Stocks, Privately Held: Atlas 5D
Research: CardioFocus, Inc.


​Contributor Disclosure(s): 
 
M. Vaseghi:

Honoraria/Speaking/Consulting: Medtronic Inc., Zoll Inc.
Stock Options, Privately Held: NeuCures, Anumana

M. Sardana:

Nothing to disclose.

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered